REVOLENS Randomized Clinical Trial: Results
Promising news from Pneumrx’s randomized clinical trial with the French Ministry of Health for their severe emphysema therapy.
From Pneumerx:
“We congratulate the investigators and the French Ministry of Health for completing this randomized clinical trial and for publishing the study results in one of the world’s top-ranked medical journals.” said Matthew Gantz, Executive VP, BTG International Inc., and President, PneumRx, Inc. “We are pleased to see a growing evidence base supporting the use of endobronchial coils to improve the lives of patients with severe emphysema and look forward to this becoming a standard of care option in France.”
The full article in the Journal of American Medicine can be read here: http://pneumrx.com/us/corporate-us/news-press-releases-detail/us-french-ministry-of-health-sponsored-revolens-study-published-in-the-janu
